Benserazide Hydrochloride is a critical chemical compound within the pharmaceutical landscape, primarily recognized for its role as an Active Pharmaceutical Ingredient (API) in the treatment of Parkinson's disease. NINGBO INNO PHARMCHEM CO.,LTD. specializes in the production of high-quality APIs like Benserazide Hydrochloride, understanding its intricate chemical structure and its significant therapeutic impact.

Chemically, Benserazide Hydrochloride is a peripherally acting aromatic L-amino acid decarboxylase inhibitor. Its molecular formula is C10H15N3O5, with a molecular weight of 257.2432. The CAS number associated with it is 322-35-0. Its physical appearance is typically a white to off-white crystalline powder. The compound's efficacy stems from its ability to selectively inhibit the decarboxylation of Levodopa in the peripheral tissues. This process is vital because Levodopa, a precursor to dopamine, needs to reach the brain to be effective in managing Parkinson's symptoms. Without Benserazide Hydrochloride, much of the administered Levodopa is converted to dopamine in the periphery, leading to diminished efficacy and increased side effects.

As a pharmaceutical intermediate, Benserazide Hydrochloride is indispensable for creating combination drug formulations that are essential for treating complex neurological conditions. The synergy it provides with Levodopa exemplifies its importance in delivering targeted and effective treatments. The precise synthesis and purification of Benserazide Hydrochloride are paramount to ensuring its pharmacological activity and patient safety.

Beyond its established use in Parkinson's, ongoing research into Benserazide immune response modulation and its effects on neuroinflammation highlights its potential as a versatile compound. This exploration into Benserazide neuroprotective properties is continually expanding the understanding of its chemical and biological significance. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying Benserazide Hydrochloride that meets stringent quality standards, supporting both current therapeutic needs and future pharmaceutical innovations.